How much does your Stem Cell Treatment for a Traumatic Brain Injury cost?
At Stem Cell Mexico, stem cell treatment for a traumatic brain injury (TBI) is quoted individually, and the exact figure is confirmed after a medical evaluation, because each brain injury is different.

The price depends on the severity and time since injury, the symptoms you want to address, the number of cells recommended, the route of administration, the level of support you need during your stay (for example, mobility assistance or a caregiver) and how long you need medical observation. You receive a written quote listing exactly what is included before paying any deposit.
For families living with the effects of a brain injury, cost is only one part of the decision. This guide also explains how regenerative treatment is thought to work after TBI, what clinical research has shown so far, and what questions to ask so you can decide with clear expectations.
Why TBI treatment plans and prices vary
Traumatic brain injury ranges from a mild concussion with lingering symptoms to a severe injury with long-term physical and cognitive disability. A responsible plan considers:
Severity and pattern of injury
Diffuse axonal injury, focal contusions, hemorrhages and post-surgical changes affect the brain differently. Imaging (MRI or CT) and neurological reports help your doctor understand which functions are affected.
Time since injury
Treatment goals differ between the subacute phase (weeks to months after injury) and the chronic phase (more than a year after injury). Most people who contact us are in the chronic phase, living with persistent deficits such as weakness on one side, balance problems, slowed thinking, memory difficulties, headaches or fatigue.
Symptoms and functional goals
Motor recovery, speech, cognition, mood and sleep may each be priorities. Defining measurable goals with you and your family is part of the evaluation.
Cell dose and route
Neurological protocols often use systemic delivery (intravenous infusion) and, depending on the case, other routes that your doctor may discuss. Dose and route are the biggest drivers of cell preparation costs.
Special care needs
Some patients require wheelchair-accessible transportation, help with transfers, medication administration or a longer stay. These accommodations are planned and quoted in advance.
What a typical quote includes
While every quote is individualized, it generally includes:
- Consultation with the doctor and stem cell specialist, with review of imaging, neurology or rehabilitation reports and medications.
- Pre-treatment laboratory testing (blood count, metabolic panel, urinalysis and tumor markers).
- Allogeneic mesenchymal stromal cells (MSCs) derived from donated umbilical cord tissue, prepared for your scheduled date.
- The application procedure and medical observation, often including an overnight stay with nursing supervision.
- A dedicated patient coordinator, ground transportation between the San Diego airport area and the clinic, and structured follow-up.
Flights, hotel nights outside the clinic and companion lodging are usually separate unless listed in your quote.
What this means: understanding brain injury recovery
After a TBI, the brain undergoes a primary injury (the mechanical damage at the moment of impact) and a secondary injury that can continue for weeks or months: inflammation, swelling, oxidative stress, loss of connections between neurons and scarring. According to the U.S. National Institute of Neurological Disorders and Stroke (NINDS), many people with moderate to severe TBI need long-term rehabilitation, and symptoms can persist for years.
The brain retains some capacity to reorganize (neuroplasticity), which is why physical, occupational, speech and cognitive therapies remain the foundation of recovery. Regenerative approaches are being studied as a way to support this process.
How regenerative treatment is thought to work after TBI
Mesenchymal stromal cells are not expected to replace lost neurons in large numbers. Instead, research suggests they act through signals that may:
- Reduce chronic neuroinflammation by influencing microglia and immune cells.
- Release trophic factors that support the survival of neurons and the growth of new connections.
- Support blood vessel formation in injured areas.
- Promote an environment that favors neuroplasticity, which may make rehabilitation more effective.
These mechanisms are biologically plausible and well documented in animal models. The open question is how much they translate into functional improvement in people, and which product, dose and route work best.
What the evidence says
It is essential not to treat "stem cells for TBI" as one uniform intervention. Studies differ in cell type, source, dose and delivery method, and results from one cannot be automatically applied to another.
The most rigorous human trial so far: The STEMTRA trial, published in Neurology, studied a modified bone-marrow-derived MSC product (SB623) in people with chronic motor deficits after TBI. The cells were implanted surgically, directly around the injured brain tissue, and compared with a sham surgery. Patients receiving cells showed significantly greater improvement in motor function on the Fugl-Meyer scale at 24 weeks, and a larger proportion reached a clinically meaningful improvement. Based on these data, regulators in Japan granted this specific product conditional, time-limited approval in 2024 for chronic motor paralysis after TBI.
This is important evidence that cell therapy can produce measurable benefit after chronic brain injury. However, it applies to that specific product and surgical route. That study used a different product and route than IV umbilical cord MSCs.
Broader clinical research: Reviews of TBI cell therapy trials, including a published overview of TBI cell therapy clinical trials, describe clinical studies using bone marrow, umbilical cord and other cell sources, delivered intravenously, intrathecally or directly to the brain. These studies generally report acceptable safety and improvement in some patients.
What this means for you: The evidence supports cautious optimism. Regenerative therapy for TBI is an active field, with one product reaching conditional approval in Japan. Results vary between individuals, and benefit, when it happens, is usually gradual and partial rather than complete.
Regulatory context
In the United States, the FDA has not approved stem cell products for TBI and advises patients to be cautious with unapproved therapies. In Mexico, cell therapies are regulated by COFEPRIS.
Who may be a candidate
A medical evaluation typically considers:
- Time since injury and medical stability (for example, no recent seizures that are uncontrolled, no active infection, no planned neurosurgery).
- Current deficits and realistic functional goals.
- Imaging and neurological reports.
- General health, including cardiovascular status and a cancer-free history of at least five years.
- Access to ongoing rehabilitation after treatment.
What results patients and families commonly ask about
How soon could we see changes? If improvement occurs, families often notice it gradually over weeks to months, frequently in energy, motor control or engagement in therapy.
Will it replace rehabilitation? No. Regenerative therapy is best viewed as a complement that may support the benefits of rehabilitation.
Can it be repeated? Some patients consider additional sessions based on progress. That decision should rely on documented changes, not a predetermined package.
What can affect outcomes
- Severity and location of the injury.
- Time since injury and age.
- Intensity and consistency of rehabilitation before and after treatment.
- Sleep, mood, nutrition and management of other conditions.
- Adherence to pre- and post-treatment instructions.
Preparing for treatment and travel after a brain injury
Traveling for treatment after a TBI takes more planning than a routine trip. Before your visit, share your most recent MRI or CT reports, neurology and rehabilitation notes, and a full medication list, including anti-seizure medications, blood thinners and sleep aids, so the medical team can confirm which to continue. Tell us early if you need a wheelchair-accessible vehicle, help with transfers or a caregiver nearby, and whether fatigue, light or noise sensitivity make long travel days difficult. Many families find it helpful to arrive the day before treatment, rest, and keep the schedule simple. It is also useful to record a short baseline of current abilities, such as a walking video or notes from your therapist, so changes can be compared later.
Risks and limitations
IV umbilical cord MSC infusions have generally been well tolerated in clinical research. Temporary fever, headache, fatigue or soreness can occur; rare risks include allergic reactions, infection and thrombotic events. Surgical delivery routes used in some trials carry additional procedural risks. Results vary: the degree of change differs from patient to patient.
Questions to ask during your evaluation
- Which of my symptoms is this treatment intended to support?
- What dose and route do you recommend, and why?
- How will we measure change (motor scales, cognitive tests, therapist reports)?
- What should my rehabilitation plan look like afterward?
- What exactly is included in the quote, including any special care needs?
Bottom line
Stem cell treatment for a traumatic brain injury at Stem Cell Mexico is quoted individually, based on the injury, goals, dose, route and level of care required. Clinical research shows encouraging evidence, including positive results with a specific surgically implanted cell product. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your injury, goals and medical history, and provides a transparent written quote before you decide.
References
- National Institute of Neurological Disorders and Stroke (NINDS, NIH): Traumatic brain injury (opens in a new tab)
- Kawabori M et al. Mesenchymal stromal cell implants for chronic motor deficits after traumatic brain injury (STEMTRA trial). Neurology, 2024 (opens in a new tab)
- Traumatic brain injury and stem cells: an overview of clinical trials, the current treatments and future therapeutic approaches (review, PMC) (opens in a new tab)
